trending Market Intelligence /marketintelligence/en/news-insights/trending/ipp0qy5ri8oakp69wq1wsa2 content esgSubNav
In This List

Takeda-Shire deal gets approval from Japan Fair Trade Commission

Blog

Global M&A By the Numbers: Q3 2021

Blog

Post-webinar Q&A: Global Credit Risk Trends 2021 and Beyond

Blog

University Essentials: From Crisis to Resilience – Navigating Sustainable Recovery

Blog

EV impact; vaccines to boost job market; coal supply constraints


Takeda-Shire deal gets approval from Japan Fair Trade Commission

Takeda Pharmaceutical Co. Ltd. said the Japan Fair Trade Commission granted unconditional clearance to its £46 billion takeover of Dublin-based biotech Shire PLC.

The deal previously received regulatory approvals in the U.S., China and Brazil. Meanwhile, the European Commission will decide whether to approve the acquisition Nov. 6.

Closing of the transaction is still subject to certain other conditions, including remaining regulatory clearances and approvals from both companies' shareholders.